Literature DB >> 11872627

Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer.

Lor-wai Tan1, Tina Bianco, Alexander Dobrovic.   

Abstract

Intercellular communication via gap junctions is a mechanism for tumor suppression. Connexin 26 (Cx26) is a structural component of gap junctions expressed by breast epithelial cells. Expression levels of Cx26 are reduced in many breast tumors. Methylation-sensitive single-stranded conformation analysis showed variable methylation in the promoter region CpG island in 11 out of 20 (55%) breast cancer patients. Heterogeneity in methylation patterns was observed both between and within tumors. The degree of methylation ranged from a few CpG dinucleotides to almost all the CpG dinucleotides in the analyzed region. The most frequently methylated CpG was in an Sp1 site known to be important for Cx26 gene expression. One of eight breast cancer cell lines (MD-MBA-453) was methylated in the promoter region and did not express Cx26. Treatment of MDA-MB-453 with 5-aza-2'-deoxycytidine resulted in the re-expression of Cx26 mRNA. Methylation of the promoter region is likely to be an important mechanism in modulating the expression of Cx26 in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872627     DOI: 10.1093/carcin/23.2.231

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

Review 1.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

2.  Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor.

Authors:  Shohreh Alizadeh Shargh; Meral Sakizli; Vahid Khalaj; Abolfazl Movafagh; Hamidreza Yazdi; Elmira Hagigatjou; Aresou Sayad; Neda Mansouri; Seyed Abdolreza Mortazavi-Tabatabaei; Hamid Reza Khorram Khorshid
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

Review 3.  Insights into inner ear-specific gene regulation: Epigenetics and non-coding RNAs in inner ear development and regeneration.

Authors:  Angelika Doetzlhofer; Karen B Avraham
Journal:  Semin Cell Dev Biol       Date:  2016-11-09       Impact factor: 7.727

Review 4.  Connexins and gap junctions in mammary gland development and breast cancer progression.

Authors:  Elizabeth McLachlan; Qing Shao; Dale W Laird
Journal:  J Membr Biol       Date:  2007-07-28       Impact factor: 1.843

Review 5.  Breast cancer epigenetics: normal human mammary epithelial cells as a model system.

Authors:  Rebecca A Hinshelwood; Susan J Clark
Journal:  J Mol Med (Berl)       Date:  2008-08-21       Impact factor: 4.599

6.  Identifying hypermethylated CpG islands using a quantile regression model.

Authors:  Shuying Sun; Zhengyi Chen; Pearlly S Yan; Yi-Wen Huang; Tim H M Huang; Shili Lin
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

7.  GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.

Authors:  Karen Chiam; Margaret M Centenera; Lisa M Butler; Wayne D Tilley; Tina Bianco-Miotto
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

8.  Preprocessing differential methylation hybridization microarray data.

Authors:  Shuying Sun; Yi-Wen Huang; Pearlly S Yan; Tim Hm Huang; Shili Lin
Journal:  BioData Min       Date:  2011-05-16       Impact factor: 2.522

Review 9.  Regulation of connexin signaling by the epigenetic machinery.

Authors:  Mathieu Vinken
Journal:  Biochim Biophys Acta       Date:  2015-11-10

10.  Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection.

Authors:  Lasse S Kristensen; Thomas Mikeska; Michael Krypuy; Alexander Dobrovic
Journal:  Nucleic Acids Res       Date:  2008-03-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.